Our research projects
Find out more about the research projects you're currently helping us to fund around the country.
118 results found.
Revolutionising stem cell transplants to treat acute myeloid leukaemia (AML)
Professor Wynn is developing and testing a new type of stem cell transplant which he hopes could be a better treatment option for people with acute myeloid leukaemia (AML)
Using special cells in the bone marrow to help improve treatment of AML
Read more about how Dr Tissot and her team plan to study special cells in the bone marrow to help predict treatment outcomes and develop better treatments for people with AML.
Unlocking new hope: developing new, effective treatments for people with myeloma and AML
Read more how Dr Luciano Nicosia is investigating a new drug to see if it might be a new way to treat myeloma and AML.
Read more how Dr Hamilton and his team are researching better ways to prevent, detect, and treat infections in people with blood cancer that is more tailored to each person’s needs.
Read more how Dr Hamilton and his team are researching better ways to prevent, detect, and treat infections in people with blood cancer that is more tailored to each person’s needs.
Understanding how leukaemia stem cells may help develop new treatments for AML
Read more about Dr Nisha Narayan who is exploring a new technique using leukaemia stem cells to predict how individuals with AML might respond to existing treatments.
Making CAR T-cell therapy more accessible for people with blood cancer
Dr David Coe is researching a new, quicker way to make CAR T-cells so more people with blood cancer can access this life-saving treatment.
Understanding how B-cell acute lymphoblastic leukaemia (B-ALL) spreads to the brain
B-cell acute lymphoblastic leukaemia (B-ALL) often spreads to the brain and spinal cord, making it challenging to treat. Dr Duguid will develop a new way of studying brain tissue in detail to find new and more effective treatments.
Understanding more the use of CT scans for children with blood cancer
Dr McNally’s research is exploring patterns in data to try to understand any potential risk of CT scans to help doctors to personalise treatment to each child based on their individual risk level.
Understanding how acute myeloid leukaemia (AML) can go undetected by the immune system
Dr Lappin wants to understand how cancer cells can avoid detection by the immune system so she can find ways to help it to better target the cancer cells.
Finding new ways to stop leukaemia and lymphoma growing
Both leukaemia and lymphoma can be caused mistakes in our DNA which can switch on ‘enhancers’ that cause the cancer cells to grow and divide. Dr Feldhahn is studying enhancers in more detail to understand which ones are helping blood cancers to grow.
Improving CART-cell therapy for people with T-cell acute lymphoblastic leukaemia (T-ALL)
Dr Maciocia is researching ways to help improve a new CART-cell therapy, making it more effective so people remain cancer free for longer.
Understanding the role of immune cells play following a bone marrow transplant
Dr Right and his team want to understand more about graft verses leukaemic (GVL) effect and graft-versus-host disease (GVHD) after a bone marrow transplant.
A new approach to a treating fatigue in people with chronic lymphocytic leukaemia (CLL)
Many people with chronic lymphocytic leukaemia (CLL) experience fatigue, a type of extreme tiredness. Dr Bartlett is researching to see if a home-based exercise and diet program can reduce fatigue and improve quality of life for people with this disease.
Understanding why some people with chronic lymphocytic leukaemia (CLL) get more infections
Dr Quek wants to better understand why many people with CLL have a high risk of developing infections following treatment by analysing blood and immune cells. She hopes to find new ways to protect people and improve their quality of life.
Finding new ways to target blood cancer with less side effects
Dr Örd wants to understand more about molecules that block a specific protein which many blood cancers rely on to grow and survive.
Using the immune system to develop a new treatment for non-Hodgkin lymphoma (NHL)
Dr Blunt and his team are looking for new way to treat people with NHL using immunotherapy that activates the immune system to attack lymphoma cells.
A new way of treating acute myeloid leukaemia (AML) in older people by reducing inflammation
Many people with acute myeloid leukaemia (AML) see their cancer come back. Dr Singh is studying a group of proteins to understand more about why drugs stop working.
A new way of treating acute myeloid leukaemia (AML) in older people by reducing inflammation
Older people are more likely to develop AML and it can be harder to treat. Dr Valletta is researching if using drugs that can block inflammation alongside traditional drug treatments will help older people with AML respond better to treatment.
